Vivo Capital, LLC Valneva Se Put Options Transaction History
Vivo Capital, LLC
- $683 Million
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VALN
# of Institutions
11Shares Held
718KCall Options Held
0Put Options Held
0-
General American Investors CO Inc354KShares$1.35 Million0.15% of portfolio
-
Wells Fargo & Company San Francisco, CA216KShares$822,6050.0% of portfolio
-
Alpha Centric Advisors LLC San Juan, PR118KShares$449,5800.6% of portfolio
-
Ironwood Investment Management LLC Boston, MA25KShares$95,3330.08% of portfolio
-
Morgan Stanley New York, NY3.56KShares$13,5480.0% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $263M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...